Arthritis & RheumatologyBurgers LE, Allaart CF, Huizinga TWJ, et al. Brief report: clinical trials aiming to prevent rheumatoid arthritis cannot detect prevention without adequate risk stratification: a trial of methotrexate versus placebo in undifferentiated arthritis as an example. Arthritis Rheumatol ...
Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken). 2012 May;64(5):640-7.[Abstract][Full Text] 70. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Comparison of treatment...
The American College of Rheumatology states that no herbal medicines have health claims supported by high quality evidence and thus they do not recommend their use. There is no scientific basis to suggest that herbal supplements advertised as "natural" are safer for use than conventional medications ...
Hadjinicolaou AV, Nisar MK, Bhagat S, Parfrey H, Chilvers ER, Ostor AJK (2011) Non-infectious pulmonary complications of newer biological agents for rheumatic diseases—a systematic literature review. Rheumatology (Oxford) 50:2297–2305 Pearce F, Johnson SR, Courtney P (2012) Interstitial lung ...
Arthritis & RheumatologyKhan NA, Singh M, Spencer HJ, et al. Randomized controlled trials of rheumatoid arthritis registered at ClinicalTrials.gov: what gets published and when. Arthritis Rheumatol 2014;66:2664-74.Khan NA, Singh M, Spencer HJ, Torralba KD. Randomized controlled trials of ...
Exploring perceptions of using preference elicitation methods to inform clinical trial design in rheumatology: A qualitative study and OMERACT collaboration Megan Thomas, Deborah A. Marshall, Adalberto Loyola Sanchez, Susan J. Bartlett, ... Glen S. Hazlewood ...
Yocum DEet al. (2004) Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.Rheumatology (Oxf)43: 992–999 ArticleCASGoogle Scholar Rep MHet al. (1997) Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does...
American College of Rheumatology AE: adverse event CTLA4–Ig: cytotoxic T lymphocyte-associated antigen 4–IgG1 DMARD: disease-modifying antirheumatic drug HAQ: Health Assessment Questionnaire IL: interleukin RA: rheumatoid arthritis SF-36: Short Form 36-Item Health Survey TNF: tumor necro...
A primary care cohort study using data from clinical practice research. Oxford Academic https://academic.oup.com/rheumatology/article/57/6/977/4904191 (2018). Zhang, Y. et al. Improved survival in rheumatoid arthritis: a general population-based cohort study. Ann. Rheum. Dis. 76, 408–413 ...
Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial. Objective . To determine the discriminant validity of the core set of outcome measures proposed by the American College of Rheumatology (ACR) and the Outcome Measures in Clinical Trials (OMERACT) ...